Healthcare Distribution Alliance
Registered Principal Details
Business Or Interest:
Healthcare
Lobbying Interests:
Issues related to Healthcare and the biennial budget.
CEO Name:
Robert Mauch
Healthcare
Lobbying Interests:
Issues related to Healthcare and the biennial budget.
CEO Name:
Robert Mauch
Contact
MD
Matthew DiLoreto
901 N. Glebe Rd
Arlington, VA 22203
(703) 787-0000
ccastro@multistate.us
https://www.hda.org/
901 N. Glebe Rd
Arlington, VA 22203
(703) 787-0000
ccastro@multistate.us
https://www.hda.org/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Roxolana Kozyckyj | Exclusive Duties No | Authorized On 2/26/2021 | Withdrawn On 11/24/2021 |
| Annette M Cruz | Exclusive Duties No | Authorized On 3/8/2021 | Withdrawn On N/A |
| Nathan J Halbach | Exclusive Duties No | Authorized On 3/8/2021 | Withdrawn On N/A |
| Michael Rogowski | Exclusive Duties No | Authorized On 3/8/2021 | Withdrawn On N/A |
| Travis Butchello | Exclusive Duties No | Authorized On 2/15/2022 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Senate Bill 753
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
1/13/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
For
Notification Date1/13/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
7/23/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
7/23/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Development, drafting or introduction of a proposal relating to
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Action Intended To Affect
Legislative matter
Notification Date
11/5/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
11/5/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations
drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations
Action Intended To Affect
Legislative matter
Notification Date
10/27/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
10/27/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
LRB 3339 - Office of Prescription Drug Affordability
LRB 3339 - Office of Prescription Drug Affordability
Action Intended To Affect
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
LRB 3337 PSAO Licensure
LRB 3337 PSAO Licensure
Action Intended To Affect
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
LRB 3331 - Drug importation
LRB 3331 - Drug importation
Action Intended To Affect
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
LRB 2313 - Prescription Drug Review Board
LRB 2313 - Prescription Drug Review Board
Action Intended To Affect
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $12,045.00 |
2021 July - December $15,000.00 |
2022 January - June $0.00 |
2022 July - December $15,086.00 |
Total $42,131.00 |
| Total Hours Communicating | 2021 January - June 1.00 |
2021 July - December 3.25 |
2022 January - June 0.50 |
2022 July - December 2.00 |
Total 6.75 |
| Total Hours Other | 2021 January - June 7.25 |
2021 July - December 11.00 |
2022 January - June 9.75 |
2022 July - December 5.50 |
Total 33.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 1% |
2022 July - December |
Total < 1% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 30% |
2022 January - June |
2022 July - December 75% |
Total 25% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 4% |
2022 July - December |
Total 1% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication